Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
ImmuCell Corporation (ICCC) had Consolidated Net Income/Loss of $-0.14M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$5.51M |
|
$-0.14M |
|
$3.14M |
|
$2.36M |
|
$5.49M |
|
$0.02M |
|
$-0.16M |
|
$-0.14M |
|
$-0.14M |
|
$-0.14M |
|
$-0.14M |
|
|
Consolidated Net Income/Loss |
$-0.14M |
$-0.14M |
|
$0.02M |
|
$0.73M |
|
9.05M |
|
9.05M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$16.83M |
|
$24.34M |
|
$28.91M |
|
$45.73M |
|
$4.00M |
|
$7.90M |
|
$11.93M |
|
$15.93M |
|
$29.80M |
|
$29.70M |
|
$29.80M |
|
9.05M |
|
| Cash Flow Statement Financials | |
$1.99M |
|
$-1.05M |
|
$-0.82M |
|
$3.76M |
|
$3.89M |
|
$0.13M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.21 |
|
-- |
|
-- |
|
0.21 |
|
0.32 |
|
42.92% |
|
0.36% |
|
0.36% |
|
-- |
|
-2.46% |
|
-2.54% |
|
$0.95M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.32 |
|
2.16 |
|
41.76 |
|
-0.47% |
|
-0.47% |
|
-0.31% |
|
-0.37% |
|
$3.29 |
|
$0.10 |
|
$0.22 |
|